Swiss National Bank’s Day One Biopharmaceuticals DAWN Stock Holding History

Swiss National Bank’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.03M	Hold	141,500	–	–	﹤0.01%	1632
2025 Q4	$1.32M	Buy	141,500 +15,700	+12%	+$131K	﹤0.01%	2054
2025 Q3	$887K	Hold	125,800	–	–	﹤0.01%	2202
2025 Q2	$818K	Buy	125,800 +18,300	+17%	+$126K	﹤0.01%	2212
2025 Q1	$852K	Sell	107,500 -10,300	-9%	-$111K	﹤0.01%	2196
2024 Q4	$1.49M	Buy	117,800 +3,000	+3%	+$41.7K	﹤0.01%	2019
2024 Q3	$1.6M	Buy	114,800 +19,400	+20%	+$277K	﹤0.01%	1987
2024 Q2	$1.31M	Hold	95,400	–	–	﹤0.01%	2037
2024 Q1	$1.58M	Hold	95,400	–	–	﹤0.01%	1971
2023 Q4	$1.39M	Hold	95,400	–	–	﹤0.01%	2057
2023 Q3	$1.17M	Sell	95,400 -15,900	-14%	-$207K	﹤0.01%	2151
2023 Q2	$1.33M	Buy	+111,300	New	+$1.45M	﹤0.01%	2147

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Swiss National Bank's DAWN Position: Q1 2026 in Review

Swiss National Bank held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 141,500 shares worth $3.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Swiss National Bank first reported a position in DAWN in Q2 2023 and has held it in 12 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

Swiss National Bank held 141,500 shares of Day One Biopharmaceuticals worth $3.03M as of Q1 2026.
Swiss National Bank left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
Day One Biopharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1632 holding.
Swiss National Bank first reported a position in Day One Biopharmaceuticals in Q2 2023 and has held it in 12 quarters since.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.